Alkermes plc (ALKS) at a glance

Alkermes plc (ALKS) is a mid-cap Healthcare company. It trades at $45.97, with a P/E of 49.2, a 9.8% profit margin and revenue growth of 28.2%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Value (24/100). It is a relatively defensive holding with below-market volatility.

Price

$45.97

Market cap

$7.38B

P/E ratio

49.2

Dividend yield

None

Beta

0.33

52-week range

$25.17 to $55.67